SEC Form 4 · accession 0001127602-18-003918
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Jonas
Officer — EVP Legal Affairs,Gen. Counsel
Period of report
Feb 2, 2018
Accepted (ET)
Feb 5, 2018 · 2:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 2, 2018 | M | 2,000 | $32.93 | A | 18,893 | D | |
| Common Stock | Feb 2, 2018 | F | 1,419 | $63.21 | D | 17,474 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sars (Stock Appreciation Rights)F1 | $32.93 | Feb 2, 2018 | M | 2,000 | D | — | Jun 1, 2023 | Common Stock | 2,000 | 2,000 | D |
Explanation of responses
- F1The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.